Events

Biotech Connection Singapore and Joyful Frog Digital Incubator (JFDI) have teamed up for the first time to present a Happy Hour Networking Event on Friday April 10th.

We will welcome our special guests, the founding team behind Genome Editing to share with us their experience starting up in Singapore. Genome Editing is the ONLY local biotech startup in Singapore selected to compete in the highly competitive OneStart business plan competition in Europe this year.

Patents give inventors exclusive rights for a limited period of time and thus provide incentives to undertake risky research projects. They also spur private investment to commercialise products and services.

The global Med Tech market is projected to grow at a rate of 4.4% annually, making it one of the fastest developing industry sectors. The stage is set for Singapore to grow into a vibrant, global Med Tech hub with an industry-ready workforce, “plug and play” infrastructure, and the growth of public-private partnerships, along with considerable government support.

The ability to write in a clear, informative and engaging way is a critical part of the scientist’s toolbox, as it allows the broader community to share in the excitement of basic scientific discovery. Unfortunately, few scientists receive formal training in communication, and the need for well-written scientific material has never been greater.

Thursday, January 23, 2014 6:30 PM - 9:30 PM Amphitheatre, Duke-NUS Graduate Medical School 8 College Rd Singapore 169857 (map) [bs-social-share style="button-no-text" colored="0" sites="facebook,twitter,whatsapp,email" title="Share" show_title="0" icon="" heading_color="" heading_style="default" bs-show-desktop="1" bs-show-tablet="1" bs-show-phone="1" bs-text-color-scheme="" custom-css-class="" custom-id="" css=""] The era of Big Data is upon us. Advances in technology allow us not Read more…

Tuesday, November 5, 2013 6:00 PM - 9:00 PM [bs-social-share style="button-no-text" colored="0" sites="facebook,twitter,whatsapp,email" title="Share" show_title="0" icon="" heading_color="" heading_style="default" bs-show-desktop="1" bs-show-tablet="1" bs-show-phone="1" bs-text-color-scheme="" custom-css-class="" custom-id="" css=""] The Medical Technology sector has been identified as a key growth area for Singapore’s future economy. The growth of our local corporate enterprise is pivotal Read more…

Singapore’s biomedical sciences (BMS) initiative began with a bang in 2000 with a S$6 billion government commitment over 5 years earmarked to establish new research centres, attract multi-national companies (MNCs), and to build infrastructure such as the Biopolis. Government spending on R&D has now increased to S$16.1 billion for phase 3 of the BMS initiative from 2011 to 2015, with the aim of “capturing opportunities for greater economic and health impact”.